Nature Communications (Feb 2022)
Dihydroceramide- and ceramide-profiling provides insights into human cardiometabolic disease etiology
Abstract
Among lipid classes, ceramides are linked to impaired cardiometabolic health. Here the authors report the association of specific ceramides and dihydroceramides on the risk of developing type 2 diabetes and or cardiovascular disease in a prospective population cohort.